Page 3 - Sciad Communications News Today

Taipei, Taiwan, 1st November 2022 / Sciad Newswire / BRIM Biotechnology, Inc. ("BRIM," TPEx 6885) is pleased to announce that it has received agreement from the US Food and Drug Administration (FDA) on the Phase 3 clinical trial design for its lead candidate for Dry Eye Disease (DED), BRM421, at the End of Phase 2 M...

London, UK, 22 September 2022 / Sciad Newswire / Connect in Pharma — the new annual event from Easyfairs — had its debut launch on 14 & 15 September in Geneva. Key players from companies in the pharmaceutical industry, including Bayer, Merck, Pfizer, Roche, Johnson & Johnson and GSK, among other, came togeth...

Cambridge, UK, 14th September 2022 / Sciad Newswire / Domainex Ltd., based in Cambridge UK, is a leading provider of integrated drug discovery services. As a result of the work carried out by Domainex during an in-house research programme to identify inhibitors of protein kinases TBK1 and IKK-epsilon, DMXD-011 has b...

Geneva-based event pledges five Swiss francs per visitor to support new drug development projectLondon, UK, 12 July 2022 / Sciad Newswire / The organisers of Connect in Pharma announce today that for every visitor to the Geneva-based event, five Swiss francs will be donated to EspeRare Foundation, a not-for-profit o...

Cambridge and Stevenage, United Kingdom, 30th June 2022 / Sciad Newswire / NRG Therapeutics Ltd., an innovative neuroscience company targeting mitochondrial dysfunction, and Domainex Ltd., today announce a collaboration focused on developing novel small molecule disease-modifying medicines for the treatment of Parki...

BRIM Biotechnology enters OTC trading in TaiwanTaipei, Taiwan, 23rd June 2022 / Sciad Newswire / BRIM Biotechnology, Inc. (BRIM, TWSE 6995) enters OTC trading in Taiwan on 23rd June 2022, CST. The news was announced at the company’s first earnings call on 22nd June 2022....

Taipei, Taiwan, 23rd June 2022 / Sciad Newswire / BRIM Biotechnology, Inc. (BRIM, TWSE 6995) enters OTC trading in Taiwan on 23rd June 2022, CST. The news was announced at the company’s first earnings call on 22nd June 2022.Established in July 2013, BRIM is a clinical-stage company developing novel regenerative ther...

Talk from Roche engineer Tiffany McIntire will highlight opportunities for the pharma sector to reinvent packaging to be more focused on patient needs in areas such as medication taken orallyLondon, United Kingdom, 31 May 2022 / Sciad Newswire / Easyfairs announces today that Tiffany McIntire, a Principal Human Fact...

Press release content from PR Newswire. The AP news staff was not involved in its creation.

/PRNewswire/ --Darling Ingredients Inc. (NYSE: DAR) today announced that its health brand Rousselot®, the global leader of collagen-based solutions1, launched...